First-Line Treatment of Non-Small-Cell Lung Cancer (NSCLC) with Immune Checkpoint Inhibitors

BioDrugs ◽

10.1007/s40259-019-00339-4 ◽

2019 ◽

Vol 33 (2) ◽

pp. 159-171 ◽

Author(s):

Olivier Bylicki ◽

Helene Barazzutti ◽

Nicolas Paleiron ◽

Jacques Margery ◽

Jean-Baptiste Assié ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Immune Checkpoint ◽

Immune Checkpoint Inhibitors ◽

Checkpoint Inhibitors ◽

Line Treatment ◽

Small Cell Lung ◽

First Line Treatment

Download Full-text

Immune checkpoint inhibitors plus chemotherapy versus chemotherapy or immunotherapy for first-line treatment of advanced non-small cell lung cancer: a generic protocol

Cochrane Database of Systematic Reviews ◽

10.1002/14651858.cd013009 ◽

2018 ◽

Author(s):

Nicholas LX Syn ◽

Raheleh Roudi ◽

Louis Zizhao Wang ◽

Lingzhi Wang ◽

Marie Loh ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Immune Checkpoint ◽

Immune Checkpoint Inhibitors ◽

Checkpoint Inhibitors ◽

Line Treatment ◽

Small Cell Lung ◽

First Line Treatment

Download Full-text

Chemoimmunotherapy versus immune checkpoint inhibitors monotherapy as first‐line treatment for advanced non‐small cell lung cancer

Thoracic Cancer ◽

10.1111/1759-7714.14304 ◽

2022 ◽

Author(s):

Alessandro Rizzo

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Immune Checkpoint ◽

Immune Checkpoint Inhibitors ◽

Checkpoint Inhibitors ◽

Line Treatment ◽

Small Cell Lung ◽

First Line Treatment

Download Full-text

Immune checkpoint inhibitors (anti PD‐1 or anti PD‐L1) plus platinum‐etoposide versus platinum‐etoposide alone for first‐line treatment of extensive small cell lung cancer

Cochrane Database of Systematic Reviews ◽

10.1002/14651858.cd014809 ◽

2021 ◽

Author(s):

Ya Gao ◽

Shuzhen Shi ◽

Ming Liu ◽

Fanqi Wu ◽

Junhua Zhang ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Immune Checkpoint ◽

Immune Checkpoint Inhibitors ◽

Checkpoint Inhibitors ◽

Line Treatment ◽

Small Cell Lung ◽

First Line Treatment

Download Full-text

A Changing of the Guard: Immune Checkpoint Inhibitors With and Without Chemotherapy as First Line Treatment for Metastatic Non-small Cell Lung Cancer

Frontiers in Oncology ◽

10.3389/fonc.2019.00195 ◽

2019 ◽

Vol 9 ◽

Author(s):

Jose M. Pacheco ◽

D. Ross Camidge ◽

Robert C. Doebele ◽

Erin Schenk

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Immune Checkpoint ◽

Immune Checkpoint Inhibitors ◽

Checkpoint Inhibitors ◽

Line Treatment ◽

Small Cell Lung ◽

First Line Treatment

Download Full-text

Optimizing Patient Outcomes with PD‐1/PD‐L1 Immune Checkpoint Inhibitors for the First‐Line Treatment of Advanced Non–Small Cell Lung Cancer

Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ◽

10.1002/phar.2364 ◽

2020 ◽

Vol 40 (3) ◽

pp. 239-255 ◽

Author(s):

Ninh M. La‐Beck ◽

Dung T. Nguyen ◽

Alex D. Le ◽

Saeed K. Alzghari ◽

Saralinh T. Trinh

Keyword(s):

Lung Cancer ◽

Patient Outcomes ◽

Immune Checkpoint ◽

Immune Checkpoint Inhibitors ◽

Checkpoint Inhibitors ◽

Line Treatment ◽

Small Cell Lung ◽

First Line Treatment

Download Full-text

Meta-analysis of the Efficacy and Tolerability of Immune Checkpoint Inhibitors Combined with Chemotherapy in First-line Treatment of Small Cell Lung Cancer

Clinical Therapeutics ◽

10.1016/j.clinthera.2020.12.017 ◽

2021 ◽

Author(s):

Jiao Wu ◽

Aifen Zhang ◽

Lu Li ◽

Sicheng Liu ◽

Fang Yang ◽

...

Keyword(s):

Lung Cancer ◽

Immune Checkpoint ◽

Immune Checkpoint Inhibitors ◽

Checkpoint Inhibitors ◽

Meta Analysis ◽

Line Treatment ◽

Small Cell Lung ◽

First Line Treatment

Download Full-text

Current status of immune-checkpoint inhibitors in the first-line treatment of metastatic non-small cell lung cancer

Annals of Oncology ◽

10.1093/annonc/mdz325.001 ◽

2019 ◽

Vol 30 ◽

pp. vi32

Author(s):

Kentaro Tanaka

Keyword(s):

Lung Cancer ◽

Immune Checkpoint ◽

Immune Checkpoint Inhibitors ◽

Checkpoint Inhibitors ◽

Current Status ◽

Line Treatment ◽

Small Cell Lung ◽

First Line Treatment

Download Full-text

A single institution study evaluating outcomes of PD-L1 high KRAS-mutant advanced non-small cell lung cancer (NSCLC) patients treated with first line immune checkpoint inhibitors

Cancer Treatment and Research Communications ◽

10.1016/j.ctarc.2021.100330 ◽

2021 ◽

Vol 27 ◽

pp. 100330 ◽

Author(s):

Adi Kartolo ◽

Harriet Feilotter ◽

Wilma Hopman ◽

Andrea S. Fung ◽

Andrew Robinson

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Immune Checkpoint ◽

Immune Checkpoint Inhibitors ◽

Checkpoint Inhibitors ◽

Small Cell Lung ◽

Single Institution ◽

Download Full-text

Immune checkpoint blockade (ICB) for first line treatment in non-small cell lung cancer (NSCLC)

Translational Cancer Research ◽

10.21037/tcr.2016.09.20 ◽

2016 ◽

Vol 5 (S3) ◽

pp. S408-S410

Author(s):

Rafael Rosell ◽

Niki Karachaliou ◽

Aaron Sosa ◽

Santiago Viteri

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Immune Checkpoint ◽

Immune Checkpoint Blockade ◽

Line Treatment ◽

Small Cell Lung ◽

First Line Treatment

Download Full-text

Immune checkpoint inhibitors as first-line and salvage therapy for advanced non-small-cell lung cancer

Future Oncology ◽

10.2217/fon-2016-0086 ◽

2016 ◽

Vol 12 (15) ◽

pp. 1805-1822 ◽

Author(s):

Marios P Decatris ◽

Kenneth J O'Byrne

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Immune Checkpoint ◽

Salvage Therapy ◽

Immune Checkpoint Inhibitors ◽

Checkpoint Inhibitors ◽

Small Cell Lung ◽

Download Full-text